Bill
S 2035
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
194th Legislature (2025-2026)
Introduced by Jason Lewis and 1 co-sponsor
Massachusetts bill eliminates federal tax deductions for pharmaceutical companies' direct-to-consumer drug advertising, increasing their tax costs and potentially reducing marketing spending.
Reporting date extended to Thursday June 25, 2026